Exact Mass: 380.1377

Exact Mass Matches: 380.1377

Found 24 metabolites which its exact mass value is equals to given mass value 380.1377, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Varespladib

2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetic acid

C21H20N2O5 (380.1372)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].

   

Decarbomethoxykopsifine

(+)-Decarbomethoxykopsifine

C21H20N2O5 (380.1372)


   
   
   

MLS001401364-01!Cilastatin sodium

MLS001401364-01!Cilastatin sodium

C16H25N2NaO5S (380.1382)


   

grandilodine C

grandilodine C

C21H20N2O5 (380.1372)


A natural product found in Kopsia grandifolia.

   

O-methylgeissolaevine

O-methylgeissolaevine

C21H20N2O5 (380.1372)


   

N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate

N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate

C18H23ClN3O4 (380.1377)


   

Cilastatin Sodium

Sodium (Z)-7-(((R)-2-amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoate

C16H25N2NaO5S (380.1382)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Varespladib

Varespladib

C21H20N2O5 (380.1372)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].

   

N-(3,4-dimethoxyphenyl)-7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazole-3-carboxamide

N-(3,4-dimethoxyphenyl)-7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazole-3-carboxamide

C21H20N2O5 (380.1372)


   

2-(4-Anilinophenoxy)acetic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester

2-(4-Anilinophenoxy)acetic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester

C21H20N2O5 (380.1372)


   

N-(3-methoxyphenyl)-1,3-dioxo-2-(2-oxolanylmethyl)-5-isoindolecarboxamide

N-(3-methoxyphenyl)-1,3-dioxo-2-(2-oxolanylmethyl)-5-isoindolecarboxamide

C21H20N2O5 (380.1372)


   

(3aR,6aS)-3-(3,4-dimethoxyphenyl)-5-(2,4-dimethylphenyl)-3a,6a-dihydropyrrolo[3,4-d]isoxazole-4,6-dione

(3aR,6aS)-3-(3,4-dimethoxyphenyl)-5-(2,4-dimethylphenyl)-3a,6a-dihydropyrrolo[3,4-d]isoxazole-4,6-dione

C21H20N2O5 (380.1372)


   

methyl 2-[4-ethyl-2-methoxy-5-oxo-2-(9H-pyrido[3,4-b]indol-1-yl)furan-3-yl]acetate

methyl 2-[4-ethyl-2-methoxy-5-oxo-2-(9H-pyrido[3,4-b]indol-1-yl)furan-3-yl]acetate

C21H20N2O5 (380.1372)


   

Methyl (9R,12R,21S)-15,20-dioxo-19-oxa-8,16-diazahexacyclo[10.6.4.01,9.02,7.09,21.012,16]docosa-2,4,6,13-tetraene-8-carboxylate

Methyl (9R,12R,21S)-15,20-dioxo-19-oxa-8,16-diazahexacyclo[10.6.4.01,9.02,7.09,21.012,16]docosa-2,4,6,13-tetraene-8-carboxylate

C21H20N2O5 (380.1372)


   

(3S)-5-Bromo-3-(tert-butyldimethylsilyloxy)-1-pivaloyloxypentane

(3S)-5-Bromo-3-(tert-butyldimethylsilyloxy)-1-pivaloyloxypentane

C16H33BrO3Si (380.1382)


   

methyl 3-ethyl-1-formyl-8-methoxy-4-oxo-6h,7h,12h-indolo[2,3-a]quinolizine-2-carboxylate

methyl 3-ethyl-1-formyl-8-methoxy-4-oxo-6h,7h,12h-indolo[2,3-a]quinolizine-2-carboxylate

C21H20N2O5 (380.1372)


   

(1r,2s,3r,14s,15s,17s)-15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione

(1r,2s,3r,14s,15s,17s)-15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione

C21H20N2O5 (380.1372)


   

6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h,7h-[1,3]dioxolo[4,5-e]isoindol-8-one

6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h,7h-[1,3]dioxolo[4,5-e]isoindol-8-one

C21H20N2O5 (380.1372)


   

5,6,7-trimethoxy-4-(4-methoxyphenyl)-3h-naphtho[2,3-d]imidazol-2-ol

5,6,7-trimethoxy-4-(4-methoxyphenyl)-3h-naphtho[2,3-d]imidazol-2-ol

C21H20N2O5 (380.1372)


   

15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione

15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione

C21H20N2O5 (380.1372)


   

(6e)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol

(6e)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol

C21H20N2O5 (380.1372)


   

(6z)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol

(6z)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol

C21H20N2O5 (380.1372)